Clinical trial
A Phase II/III Trial on Rizatriptan for Vestibular Migraine
NCT02447991 is registered in ClinicalTrials.gov with Robert W. Baloh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II/III Trial on Rizatriptan for Vestibular Migraine
- Lead sponsor
- Robert W. Baloh
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- July 31, 2020
- Enrollment
- 223 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
migrainous vertigo, vestibular migraine